Therapeutic Approaches to Alzheimer’s Disease Through Modulation of NRF2
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Approaches to Alzheimer’s Disease Through Modulation of NRF2
Authors
Keywords
NRF2, NRF2 activator, Alzheimer’s disease, Amyloid-β, Oxidative stress, ROS, Neurodegenerative disease
Journal
NEUROMOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-09
DOI
10.1007/s12017-018-08523-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2018 Alzheimer's disease facts and figures
- (2018) Alzheimers & Dementia
- Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
- (2018) Melanie P. Chin et al. AMERICAN JOURNAL OF NEPHROLOGY
- Pharmacological activation of the Nrf2 pathway by 3H-1, 2-dithiole-3-thione is neuroprotective in a mouse model of Alzheimer disease
- (2018) YuanBo Cui et al. BEHAVIOURAL BRAIN RESEARCH
- CART peptide activates the Nrf2/HO-1 antioxidant pathway and protects hippocampal neurons in a rat model of Alzheimer's disease
- (2018) Wenyu Jiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy
- (2018) Victor Tapias et al. HUMAN MOLECULAR GENETICS
- Tau-targeting therapies for Alzheimer disease
- (2018) Erin E. Congdon et al. Nature Reviews Neurology
- Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy
- (2018) Antonio Cuadrado et al. Redox Biology
- Protective roles of Amanita caesarea polysaccharides against Alzheimer's disease via Nrf2 pathway
- (2018) Zhiping Li et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Mini-GAGR, an intranasally applied polysaccharide, activates the neuronal Nrf2-mediated antioxidant defense system
- (2018) Kelsey Murphy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RPA1 binding to NRF2 switches ARE-dependent transcriptional activation to ARE-NRE–dependent repression
- (2018) Pengfei Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protective effect of 3H-1, 2-dithiole-3-thione on cellular model of Alzheimer's disease involves Nrf2/ARE signaling pathway
- (2017) Lan Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer’s disease
- (2017) Caterina Branca et al. HUMAN MOLECULAR GENETICS
- Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model
- (2017) Seung Hyun Baek et al. JOURNAL OF NEUROSCIENCE
- Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
- (2017) Zewen Liu et al. Oxidative Medicine and Cellular Longevity
- Vanillic acid attenuates Aβ1-42-induced oxidative stress and cognitive impairment in mice
- (2017) Faiz Ul Amin et al. Scientific Reports
- Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease
- (2017) Athanassios Fragoulis et al. Redox Biology
- NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology
- (2017) Ana I. Rojo et al. Redox Biology
- An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment
- (2017) Nadine Keleku-Lukwete et al. ANTIOXIDANTS & REDOX SIGNALING
- Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
- (2016) Isabel Lastres-Becker et al. ANTIOXIDANTS & REDOX SIGNALING
- Repression of the Antioxidant NRF2 Pathway in Premature Aging
- (2016) Nard Kubben et al. CELL
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer's disease mouse model
- (2016) Chun-Yan Wang et al. NEUROBIOLOGY OF AGING
- Hydrogen sulfide ameliorates learning memory impairment in APP/PS1 transgenic mice: A novel mechanism mediated by the activation of Nrf2
- (2016) Yuangui Liu et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer’s disease models
- (2016) Stuart A Lipton et al. Cell Death & Disease
- Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors
- (2016) Sunhyo Kim et al. Scientific Reports
- Biological and physiological role of reactive oxygen species - the good, the bad and the ugly
- (2015) L. Zuo et al. Acta Physiologica
- Allicin improves endoplasmic reticulum stress-related cognitive deficits via PERK/Nrf2 antioxidative signaling pathway
- (2015) Yao-Feng Zhu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Nrf2—a therapeutic target for the treatment of neurodegenerative diseases
- (2015) Delinda A. Johnson et al. FREE RADICAL BIOLOGY AND MEDICINE
- Orientin alleviates cognitive deficits and oxidative stress in Aβ1–42-induced mouse model of Alzheimer's disease
- (2015) Linjie Yu et al. LIFE SCIENCES
- Increased Alzheimer's disease–like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy
- (2015) Gururaj Joshi et al. NEUROBIOLOGY OF AGING
- Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson’s disease by enhancing Nrf2 activity
- (2015) X. Jing et al. NEUROSCIENCE
- Antroquinonol Lowers Brain Amyloid-β Levels and Improves Spatial Learning and Memory in a Transgenic Mouse Model of Alzheimer’s Disease
- (2015) Wen-Han Chang et al. Scientific Reports
- Dimethyl fumarate in the treatment of relapsing–remitting multiple sclerosis: an overview
- (2015) Roberto Bomprezzi Therapeutic Advances in Neurological Disorders
- The neuroprotective effects of β-hydroxybutyrate on Aβ-injected rat hippocampus in vivo and in Aβ-treated PC-12 cells in vitro
- (2014) G. Xie et al. FREE RADICAL RESEARCH
- Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis
- (2014) T. Wu et al. GENES & DEVELOPMENT
- A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer
- (2014) Joshi J. Alumkal et al. INVESTIGATIONAL NEW DRUGS
- Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl
- (2014) Melanie P. Chin et al. JOURNAL OF CARDIAC FAILURE
- Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52
- (2014) Chulman Jo et al. Nature Communications
- Aβ and tau toxicities in Alzheimer’s are linked via oxidative stress-induced p38 activation: Protective role of vitamin E
- (2014) E. Giraldo et al. Redox Biology
- Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis
- (2013) Isabel Lastres-Becker et al. BRAIN
- RXR Inhibits the NRF2-ARE Signaling Pathway through a Direct Interaction with the Neh7 Domain of NRF2
- (2013) H. Wang et al. CANCER RESEARCH
- Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice
- (2013) Yanyan Zhou et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer’s disease
- (2012) A-Ryeong Gwon et al. AGING CELL
- Amelioration of Alzheimer’s disease by neuroprotective effect of sulforaphane in animal model
- (2012) Hyunjin Vincent Kim et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Keap1 Is Localized in Neuronal and Glial Cytoplasmic Inclusions in Various Neurodegenerative Diseases
- (2012) Kunikazu Tanji et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The nuclear cofactor RAC3/AIB1/SRC-3 enhances Nrf2 signaling by interacting with transactivation domains
- (2012) J-H Kim et al. ONCOGENE
- Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
- (2012) S Chowdhry et al. ONCOGENE
- Antioxidant Therapies for Alzheimer's Disease
- (2012) Ye Feng et al. Oxidative Medicine and Cellular Longevity
- Pharmacological Targeting of the Transcription Factor Nrf2 at the Basal Ganglia Provides Disease Modifying Therapy for Experimental Parkinsonism
- (2011) Agnieszka Jazwa et al. ANTIOXIDANTS & REDOX SIGNALING
- Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases
- (2011) Joshua A. Smith et al. BRAIN RESEARCH BULLETIN
- Modification of Keap1 Cysteine Residues by Sulforaphane
- (2011) Chenqi Hu et al. CHEMICAL RESEARCH IN TOXICOLOGY
- SCF/ -TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
- (2011) P. Rada et al. MOLECULAR AND CELLULAR BIOLOGY
- APP processing in Alzheimer's disease
- (2011) Yun-wu Zhang et al. Molecular Brain
- NF-E2-related factor 2, a key inducer of antioxidant defenses, negatively regulates the CFTR transcription
- (2010) Céline René et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Oxidative stress in Alzheimer disease: A possibility for prevention
- (2010) David J. Bonda et al. NEUROPHARMACOLOGY
- Stress-Activated Cap'n'collar Transcription Factors in Aging and Human Disease
- (2010) G. P. Sykiotis et al. Science Signaling
- Alzheimer’s disease and Notch signaling
- (2009) Ha-Na Woo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
- (2009) Bayani Uttara et al. Current Neuropharmacology
- Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer’s disease
- (2009) Magali Dumont et al. JOURNAL OF NEUROCHEMISTRY
- Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease
- (2009) K. Kanninen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- S-Nitrosylation of Drp1 Mediates β-Amyloid-Related Mitochondrial Fission and Neuronal Injury
- (2009) Dong-Hyung Cho et al. SCIENCE
- The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease
- (2008) Marcus J. Calkins et al. ANTIOXIDANTS & REDOX SIGNALING
- Activating Transcription Factor 3 Is a Novel Repressor of the Nuclear Factor Erythroid-Derived 2 Related Factor 2 (Nrf2) Regulated Stress Pathway
- (2008) S. L. Brown et al. CANCER RESEARCH
- Nuclear factor erythroid 2-related factor 2 protects against beta amyloid
- (2008) Katja Kanninen et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model
- (2008) Saravanan S. Karuppagounder et al. NEUROBIOLOGY OF AGING
- Evidence that γ-secretase mediates oxidative stress-induced β-secretase expression in Alzheimer's disease
- (2008) Dong-Gyu Jo et al. NEUROBIOLOGY OF AGING
- Differential Regulation of Dynein and Kinesin Motor Proteins by Tau
- (2008) R. Dixit et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started